Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Pierre Cesaro »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pierre Celsis < Pierre Cesaro < Pierre Champy  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000353 (2006) Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France]The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
000367 (2006) Jean-Pascal Lefaucheur [France] ; Isabelle Ménard-Lefaucheur [France] ; Patrick Maison [France] ; Sophie Baudic [France] ; Pierre Cesaro [France] ; Marc Peschanski [France] ; Anne-Catherine Bachoud-Lévi [France]Electrophysiological deterioration over time in patients with Huntington's disease
000384 (2006) Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France]The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's disease
000445 (2003) Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France]Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue
000493 (2002) Jean-Pascal Lefaucheur [France] ; Anne-Catherine Bachoud-Levi [France] ; Catherine Bourdet [France] ; Thierry Grandmougin [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Jean-Denis Degos [France] ; Marc Peschanski [France] ; Fabrice Lisovoski [France]Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Adult
4Female
4Humans
4Male
4Middle Aged
2Aged
2Blinking (physiology)
2Cerebral Cortex (physiopathology)
2Disease Progression
2Electric Stimulation
2Evoked Potentials, Somatosensory (physiology)
2Follow-Up Studies
2Galvanic Skin Response (physiology)
2Human
2Huntington Disease (diagnosis)
2Huntington Disease (genetics)
2Huntington Disease (physiopathology)
2Huntington disease
2Huntington's disease
2Nervous system diseases
2Parkinson disease
2Reaction Time (physiology)
2Sympathetic Nervous System (physiopathology)
1Antiparkinson Agents (therapeutic use)
1Autograft
1Biological transport
1Bromocriptine
1Bromocriptine (therapeutic use)
1CIT
1Case-Control Studies
1Cell therapy
1Corpus Striatum (metabolism)
1Deterioration
1Diagnosis
1Dopamine
1Dopamine Plasma Membrane Transport Proteins
1Dopamine agonist
1Double blind study
1Double-Blind Method
1Drug Therapy, Combination
1Early Diagnosis
1Electrodiagnosis
1Electromagnetic Fields
1Electromyography
1Electrophysiology
1Fetal Tissue Transplantation (methods)
1Fetal cell
1Fluorodeoxyglucose F18 (diagnostic use)
1Fluorodeoxyglucose F18 (pharmacokinetics)
1Graft Rejection (prevention & control)
1Hypokinesia (diagnosis)
1Hypokinesia (physiopathology)
1Immunosuppressive Agents (therapeutic use)
1Levodopa
1Ligand
1Longitudinal Studies
1Mechanism of action
1Median Nerve (physiopathology)
1Membrane Glycoproteins
1Membrane Transport Proteins (metabolism)
1Mesencephalon (embryology)
1Mesencephalon (metabolism)
1Mesencephalon (transplantation)
1Midbrain
1Nerve Tissue Proteins
1Neurologic Examination
1PET
1Palpebral reflex
1Parkinson
1Parkinson Disease (diagnosis)
1Parkinson Disease (drug therapy)
1Parkinson Disease (surgery)
1Parkinson's disease
1Performance evaluation
1Piribedil
1Piribedil (therapeutic use)
1Positron emission tomography
1Program
1Radiopharmaceuticals (diagnostic use)
1Radiopharmaceuticals (pharmacokinetics)
1Reference Values
1Reflex, Stretch (physiology)
1Sensitivity and Specificity
1Severity of Illness Index
1Silent period
1Somatosensory evoked potential
1Time Factors
1Tomography, Emission-Computed
1Transcranial Magnetic Stimulation
1Transcranial magnetic stimulation
1Treatment
1Treatment Outcome
1assessment program
1blink reflex
1bromocriptine
1clinical neurophysiology
1cortical silent period
1dopamine agonists
1dopamine transporter
1fetal transplantation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Pierre Cesaro" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Pierre Cesaro" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Pierre Cesaro
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024